Guoping Wang
Duke University(US)Duke Medical Center(US)
Publications by Year
Research Areas
Cancer-related Molecular Pathways, Renal cell carcinoma treatment, Metal complexes synthesis and properties, Cancer Immunotherapy and Biomarkers, Cardiac Fibrosis and Remodeling
Most-Cited Works
- → Structure-Based Design of Spiro-oxindoles as Potent, Specific Small-Molecule Inhibitors of the MDM2−p53 Interaction(2006)684 cited
- → Potent and Orally Active Small-Molecule Inhibitors of the MDM2−p53 Interaction(2009)176 cited
- → Preclinical Studies of TW-37, a New Nonpeptidic Small-Molecule Inhibitor of Bcl-2, in Diffuse Large Cell Lymphoma Xenograft Model Reveal Drug Action on Both Bcl-2 and Mcl-1(2007)148 cited
- → Reactivation of p53 by a specific MDM2 antagonist (MI-43) leads to p21-mediated cell cycle arrest and selective cell death in colon cancer(2008)90 cited
- → Synthesis, Crystal Structure, Stacking Effect and Antibacterial Studies of a Novel Quaternary Copper (II) Complex with Quinolone(2003)67 cited
- → Sulindac, a non-steroidal anti-inflammatory drug, mediates breast cancer inhibition as an immune modulator(2016)49 cited